tiprankstipranks
Turnstone Biologics Corp. (TSBX)
:TSBX
US Market

Turnstone Biologics Corp. (TSBX) Financial Statements

Compare
47 Followers

Turnstone Biologics Corp. Financial Overview

Turnstone Biologics Corp.'s market cap is currently $8.21M. The company's EPS TTM is $-3.248; its P/E ratio is ―; Turnstone Biologics Corp. is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $-0.77. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 19.31M$ 73.30M$ 101.29M
Gross Profit$ 16.51M$ 71.10M$ 99.28M
Operating Income$ -59.03M$ -31.63M$ 32.99M
EBITDA$ -56.23M$ -28.49M$ 35.71M
Net Income$ -55.20M$ -30.83M$ 33.27M
Balance Sheet
Cash & Short-Term Investments$ 94.78M$ 82.06M$ 161.02M
Total Assets$ 112.81M$ 114.94M$ 187.24M
Total Debt$ 3.21M$ 5.17M$ 2.68M
Net Debt$ -14.58M$ -29.57M$ -120.70M
Total Liabilities$ 14.15M$ 216.41M$ 269.10M
Stockholders' Equity$ 98.67M$ -101.47M$ -81.85M
Cash Flow
Free Cash Flow$ -67.40M$ -76.23M$ -49.03M
Operating Cash Flow$ -66.15M$ -71.06M$ -45.63M
Investing Cash Flow$ -28.09M$ -14.93M$ -3.35M
Financing Cash Flow$ 77.05M$ -2.66M$ 79.95M
Currency in USD

Turnstone Biologics Corp. Earnings and Revenue History

Turnstone Biologics Corp. Debt to Assets

Turnstone Biologics Corp. Cash Flow

Turnstone Biologics Corp. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis